Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Pharma-Bio-Med is a specialist literature search and monitoring provider for pharmaceutical, biotechnology, and medical device companies. It is part of TPR International, Inc. Rather than being a general knowledge base or self-service SaaS product, it is positioned as a high-reliability outsourced search service for drug safety, regulatory affairs, medical affairs, R&D, legal, and commercial teams.
Its core coverage includes pharmacovigilance and safety literature searches, weekly monitoring alerts, regulatory submission support, systematic reviews, R&D searches, medical device documentation support, patent and non-patent literature analysis, competitive intelligence, and drug pipeline monitoring. The website states that it can support use cases such as NDA, CER, PSUR, PADER, DSUR, PBRER, and PLLR, making it suitable for drug and device projects at different stages of the lifecycle. In terms of information sources, the team is familiar with professional databases such as Medline, Embase, Biosis, CAS, Scopus, Web of Science, LexisNexis, Clinicaltrials.gov, Citeline, Cortellis, and PatBase.
The official website does not publish packages or pricing, nor does it show a free plan or trial. Its service models include on-demand overflow support, full outsourcing, and full-time or part-time contract roles. This clearly points toward customized project-based work or long-term service contracts, with pricing available only after contacting the team to discuss requirements.
The main strengths are its strong industry focus and coverage of high-barrier use cases such as pharmacovigilance, regulatory affairs, R&D, and commercial intelligence. The team claims that each expert has more than 15 years of experience and has served leading pharmaceutical clients. The drawbacks are the lack of standard SaaS capability details: permissions management, workflows, APIs, self-hosted deployment, and system integrations are not disclosed. Pricing transparency is also limited, making it less friendly for teams looking to quickly purchase standardized software.
Pharma-Bio-Med is suitable for multinational pharmaceutical companies, biotech firms, medical device companies, and teams that need rigorous literature searches, regulatory documentation support, or pharmacovigilance monitoring—especially when internal information retrieval resources are limited but compliance requirements are high. It is not a good fit for organizations that only need a low-cost self-service search tool or want deep API integration with internal systems.
The website does not provide information about network access from China, RMB payments, or localized support, so its accessibility in China is unknown. Domestic teams may also evaluate building their own database subscription setup, or compare databases such as Embase, Scopus, Web of Science, Cortellis, and Citeline, as well as local medical literature service providers.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pharma-bio-med.com official site.
pharma-bio-med.com is an United States Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach pharma-bio-med.com directly.